Most Recent
Gilbert + Tobin boosts cybersecurity practice with partner from A&O Shearman
Gilbert + Tobin has recruited a leading cybersecurity lawyer from A&O Shearman, bolstering the firm’s tech and digital offering as clients faced heightened cyber risk.
Lawyers say 2026 will be another big year in class actions
Class action lawyers are expecting to see an increase in consumer and privacy cases this year, as well as a reinvigoration of shareholder litigation following a string of prominent losses, and many are counting on the High Court to clarify legal questions hanging over plaintiffs.
Construction PRO
Developer sues environment minister over Parramatta towers project
A Sydney developer has filed proceedings against the environment minister after a delegate found its proposal to build two towers in Parramatta would have “clearly unacceptable” impacts on views from Australia's oldest public building. 
Construction PRO
Atmos Renewables secures landmark green loan portfolio refinancing
Leading renewables developer Atmos has completed one of the sector’s largest green loan portfolio refinancings to date, with the new capital structure set to support expansion of its energy pipeline.
BHP files High Court challenge to same job, same pay orders
BHP has filed a High Court challenge to orders requiring it to pay labour hire workers at mines in central Queensland the same as its workers.
Oak Tasmania hit with $1.1M penalty over NDIS compliance failures
A Tasmanian disability group home and respite care provider has been hit with a $1.1 million penalty after admitting it failed to notify the NDIS Quality and Safeguards Commission about reportable incidents 474 times.
Moray & Agnew lures another partner from HWLE’s government practice
Moray & Agnew has poached a government partner from HWL Ebsworth for its Melbourne office, the third government lawyer to jump ship from HWLE to the firm in recent months.  
Merck fails to block Pfizer’s RSV vaccine trade mark
Merck KGaA has failed to block Pfizer’s 'Abrysvo' trade mark for its RSV vaccine, with a delegate finding no likelihood of confusion with the mark for Merck’s Mavenclad MS drug despite their visual similarities. 
SA Premier faces new defamation threat in fallout over writers festival
Author Dr Randa Abdel-Fattah has sent a second concerns notice to South Australian Premier Peter Malinauskas over comments he made during a radio interview after her invitation to the Adelaide Writers Week festival was pulled.
Target defeats split trial bid in fight over convertible stroller recall
A judge has refused to bifurcate a dispute between Smart Trikes and Target over the supply and eventual recall of allegedly unsafe convertible strollers, finding any time and cost savings were likely to prove illusory.